Skip to main content
Clinical Trials/NCT05879783
NCT05879783
Recruiting
Not Applicable

Use of Probe-based Confocal Laser Endomicroscopy to Perform Optical Biopsy for Peritoneal Nodules in Colorectal Cancer Patients During Surgery

Nanfang Hospital, Southern Medical University1 site in 1 country278 target enrollmentSeptember 15, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Colorectal Cancer
Sponsor
Nanfang Hospital, Southern Medical University
Enrollment
278
Locations
1
Primary Endpoint
Accuracy of pCLE optical biopsy
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

During surgery, peritoneal metastasis is typically confirmed pathologically through resection sample. However, this process can be time-consuming when utilizing intro-operative frozen section pathology. To address this issue, we propose utilizing confocal laser endomicroscopy to provide in situ, real-time, and in-vivo diagnosis of suspected peritoneal nodules as cancer metastasis during surgery.

Detailed Description

Peritoneal metastasis is a common metastatic site in colorectal cancer patients, and those with peritoneal metastasis often have a poor prognosis. During surgery, peritoneal metastasis is confirmed pathologically through resection sample, but frozen section pathology can take up to 30 minutes, which is a significant amount of time. To address this issue, we suggest utilizing probed-based confocal laser endoscopy (pCLE), a novel endoscopic adjunct that enables real-time in vivo histological examination of mucosal surfaces. By using intravenous fluorescent agents, pCLE highlights certain mucosal elements that facilitate an optical biopsy in real time. By providing a promising optical biopsy, CLE has the potential to enable in situ, real-time, and in vivo diagnosis of colorectal cancer patients with peritoneal nodules during surgery.

Registry
clinicaltrials.gov
Start Date
September 15, 2022
End Date
December 15, 2027
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age from over 18 to under 85 years
  • American Society of Anesthesiology (ASA) score class I,II,or III
  • Colorectal cancer
  • Patients who be about to undergo surgical treatment
  • Written informed consent

Exclusion Criteria

  • Pregnant or lactating women
  • Acute renal insufficiency or stage II to IV chronic renal insufficiency
  • Patients with severe liver damage
  • Asthma patients or patients with allergic constitution

Outcomes

Primary Outcomes

Accuracy of pCLE optical biopsy

Time Frame: 7 days

The investigators will use pCLE optical biopsy for peritoneal nodules in colorectal cancer patients and compare the pathological diagnosis between optical biopsy and surgically resected specimens.

Secondary Outcomes

  • Sensitivity, specificity of pCLE optical biopsy(7 days)
  • The positive predictive value and negative predictive value of pCLE optical biopsy(7 days)

Study Sites (1)

Loading locations...

Similar Trials